Neuroendocrine Tumor Center
Due to the very heterogeneous and complex pathologies, the treatment of neuroendocrine neoplasms requires effective interdisciplinary cooperation. The Neuroendocrine Tumor Center at the University Hospital Zurich was named a certified Center of Excellence by the
European Neuroendocrine Tumor Society (ENETS) in 2013.
Our center offers state-of-the-art diagnostic and treatment methods, for example, specialized endocrine surgery; specialized diagnostic and interventional gastroenterology; the latest methods in nuclear medicine, including Gallium-68 DOTATATE PET/CT and Lutetium-177 DOTATATE radiopeptide therapy; all relevant methods in pathology to ensure the reliable diagnosis of neuroendocrine tumors; specialized endocrinology, in particular for the evaluation of familial syndromes; and a reference center for medical oncology. The central element of the Neuroendocrine Tumor Center is the interdisciplinary tumor board. During these case discussions, everyone from the various disciplines brings their special knowledge to the table to provide for an optimal diagnosis, therapy and post-treatment of the patients entrusted to their care.
Last but not least, our oncology care is ably supported by our dedicated specialist staff.
University Hospital Zurich's oncology specialists provide care for oncology patients on an interdisciplinary basis. In
tumor boards, staff hold interdisciplinary discussions and jointly determine the best treatment for patients.
Referring physicians can register in advance and take part in the forums and present their patients to the forum or forward their patient files for evaluation in order to receive a treatment recommendation.
The tumor forum takes place every second Monday of the month in Trakt B-OPS Demonstrationssaal 2 (tract B, demonstration room 2). To present patients in a tumor forum, please contact
Dr. med. A. Siebenhüner (Chair of the Center)
Dr. R. Delaloye MD (Deputy Chair of the Center)
Research & trials
In pursuit of the continuous improvement of treatment outcomes, the Neuroendocrine Tumor Center at University Hospital Zurich offers a broad spectrum of center-based and international therapy optimization trials.
We conduct some of our clinical trials in collaboration with international organizations such as the European Organization for Research and Treatment of Cancer
(EORTC) or within the Swiss Group for Clinical Cancer Research
(SAKK). Certain trials were developed by researchers from our clinic, and some are conducted in cooperation with the pharmaceutical industry.